S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

Esperion Therapeutics (ESPR) Short Interest Ratio & Short Volume

$1.95
+0.08 (+4.28%)
(As of 05:36 PM ET)

Esperion Therapeutics Short Interest Data

Current Short Volume
19,920,000 shares
Previous Short Volume
17,670,000 shares
Change Vs. Previous Month
+12.73%
Dollar Volume Sold Short
$53.39 million
Short Interest Ratio / Days to Cover
3.0
Last Record Date
March 31, 2024
Outstanding Shares
189,400,000 shares
Float Size
168,540,000 shares
Short Percent of Float
11.82%
Today's Trading Volume
7,336,663 shares
Average Trading Volume
6,810,448 shares
Today's Volume Vs. Average
108%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Esperion Therapeutics ?

Sign up to receive the latest short interest report for Esperion Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ESPR Short Interest Over Time

ESPR Days to Cover Over Time

ESPR Percentage of Float Shorted Over Time

Esperion Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/202419,920,000 shares $53.39 million +12.7%11.8%3 $2.68
3/15/202417,670,000 shares $36.58 million +4.3%10.5%2.8 $2.07
2/29/202416,950,000 shares $42.54 million -8.7%10.0%2.8 $2.51
2/15/202418,570,000 shares $49.40 million -7.5%11.0%3 $2.66
1/31/202420,070,000 shares $42.95 million -0.6%11.9%3.3 $2.14
1/15/202420,200,000 shares $61.00 million +1.4%17.9%3.7 $3.02
12/31/202319,920,000 shares $59.56 million +9.2%17.7%4.3 $2.99
12/15/202318,240,000 shares $33.20 million +2.8%16.2%4.3 $1.82
11/30/202317,740,000 shares $23.59 million -3.1%15.7%4.6 $1.33
11/15/202318,310,000 shares $21.06 million +0.5%16.2%4.7 $1.15
10/31/202318,220,000 shares $15.10 million -5.2%17.2%4.8 $0.83
10/15/202319,220,000 shares $15.95 million -3.0%18.1%5 $0.83
9/30/202319,810,000 shares $19.41 million +20.4%18.7%5.5 $0.98
9/15/202316,460,000 shares $23.37 million +8.4%15.5%4.7 $1.42
8/31/202315,180,000 shares $24.29 million +8.5%14.3%4.8 $1.60
8/15/202313,990,000 shares $22.94 million +4.3%13.2%5 $1.64
7/31/202313,410,000 shares $21.05 million +2.9%12.7%4.9 $1.57
7/15/202313,030,000 shares $18.76 million +4.2%13.9%5.4 $1.44
6/30/202312,510,000 shares $17.39 million -9.9%13.3%5.1 $1.39
6/15/202313,880,000 shares $19.02 million +3.8%14.8%5 $1.37
5/31/202313,370,000 shares $18.18 million -8.4%14.3%3.6 $1.36
5/15/202314,600,000 shares $24.82 million No Change15.6%3.5 $1.70
10/31/202214,030,000 shares $114.06 million +5.3%N/A11.6 $8.13
10/15/202213,330,000 shares $101.31 million +6.6%N/A11.5 $7.60
9/30/202212,500,000 shares $83.75 million -0.9%N/A12.1 $6.70
9/15/202212,610,000 shares $94.83 million -5.5%N/A12.6 $7.52
8/31/202213,350,000 shares $99.59 million +8.6%N/A13.9 $7.46
8/15/202212,290,000 shares $81.97 million -1.8%N/A13.7 $6.67
7/31/202212,520,000 shares $72.24 million +3.2%N/A12.9 $5.77
7/15/202212,130,000 shares $81.39 million +2.6%N/A11.8 $6.71
6/30/202211,820,000 shares $75.18 million +6.8%N/A10.2 $6.36
6/15/202211,070,000 shares $59.00 million -4.2%N/A9.1 $5.33
5/31/202211,560,000 shares $65.89 million +13.7%N/A8.7 $5.70
5/15/202210,170,000 shares $58.78 million +15.8%N/A7.3 $5.78
4/30/20228,780,000 shares $49.87 million +10.0%N/A6.4 $5.68
4/15/20227,980,000 shares $47.00 million +8.7%N/A6.3 $5.89
3/31/20227,340,000 shares $34.06 million +36.7%N/A0 $4.64
3/15/20225,370,000 shares $24.70 million +29.7%N/A4 $4.60
2/28/20224,140,000 shares $16.93 million +18.0%N/A2.7 $4.09
2/15/20223,510,000 shares $14.00 million +11.4%N/A1.6 $3.99
Tiny Biotech Stock Wins $75 Billion Patent (Ad)

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

Find out more here >>>

ESPR Short Interest - Frequently Asked Questions

What is Esperion Therapeutics' current short interest?

Short interest is the volume of Esperion Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 19,920,000 shares of ESPR short. 11.82% of Esperion Therapeutics' shares are currently sold short. Learn More on Esperion Therapeutics' current short interest.

What is a good short interest ratio for Esperion Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ESPR shares currently have a short interest ratio of 3.0. Learn More on Esperion Therapeutics's short interest ratio.

Which institutional investors are shorting Esperion Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Esperion Therapeutics: GTS Securities LLC, Citadel Advisors LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Esperion Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.82% of Esperion Therapeutics' floating shares are currently sold short.

Is Esperion Therapeutics' short interest increasing or decreasing?

Esperion Therapeutics saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 19,920,000 shares, an increase of 12.7% from the previous total of 17,670,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Esperion Therapeutics' float size?

Esperion Therapeutics currently has issued a total of 189,400,000 shares. Some of Esperion Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Esperion Therapeutics currently has a public float of 168,540,000 shares.

How does Esperion Therapeutics' short interest compare to its competitors?

11.82% of Esperion Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Esperion Therapeutics: ADC Therapeutics SA (1.81%), Atai Life Sciences (4.81%), Nature's Sunshine Products, Inc. (0.60%), Amarin Co. plc (4.39%), Organogenesis Holdings Inc. (9.35%), Rani Therapeutics Holdings, Inc. (16.70%), UroGen Pharma Ltd. (17.87%), Precigen, Inc. (13.66%), Nkarta, Inc. (9.81%), Mereo BioPharma Group plc (1.86%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks.

What does it mean to sell short Esperion Therapeutics stock?

Short selling ESPR is an investing strategy that aims to generate trading profit from Esperion Therapeutics as its price is falling. ESPR shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Esperion Therapeutics?

A short squeeze for Esperion Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ESPR, which in turn drives the price of the stock up even further.

How often is Esperion Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ESPR, twice per month. The most recent reporting period available is March, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ESPR) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners